Towards Healthcare
Life Sciences CRM Market to Expand USD 2.29 Billion by 2034

Life Sciences CRM Market Automation, Remote Calibration & Predictive Maintenance by 2034

Market insights predict, the life science CRM industry is expected to grow from USD 1.24 billion in 2024 to USD 2.29 billion by 2034, driven by a CAGR of 6.32%. The life sciences CRM market is growing due to rising demand for patient engagement and demand for data-driven decision-making. North America’s dominance is due to the rising demand for better patient care and the rising involvement of patients in making decisions regarding their health.

Content

  • Insight Code: 5895
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The life sciences CRM market is projected to reach USD 2.29 billion by 2034, growing at a CAGR of 6.32% from 2024 to 2034.

North America is currently leading the life sciences CRM market due to the rising focus on improving the overall patient experience while receiving healthcare.

The life sciences CRM market includes five segments such as by functionality, by deployment mode, by application, by end-user, and by region.

Some key players include Veeva Systems, Salesforce, Oracle Life Sciences, IQVIA Technologies, Microsoft Dynamics 365 for Healthcare & Pharma, etc.

Key trends include rising patient-centric care, evidence-based decision-making, and improving the overall healthcare experience.

Data gathering, customer entry, customer interactions, analysis and planning, and feedback and improvement are the five pillars of a successful CRM strategy.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions